Welcome to our dedicated page for Bankwell Financial Group SEC filings (Ticker: BWFG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bankwell Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bankwell Financial Group's regulatory disclosures and financial reporting.
Bankwell Financial Group director granted restricted stock
Bankwell Financial Group director Kevin D. Leitao received a grant of 1,455 shares of common stock on February 9, 2026 under the company’s 2022 stock plan. The award vests in three equal installments of 485 shares on February 7, 2027, 2028, and 2029.
A prior restricted stock grant of 1,800 shares from February 7, 2025 is also outstanding, with 600 shares vested on February 7, 2026 and another 600 shares scheduled to vest on February 7, 2027 and 2028, respectively.
Bankwell Financial Group director Carl M. Porto reported an equity award of common stock. On February 9, 2026, he received 1,455 shares of restricted stock at $0 per share under the 2022 Stock Plan. These shares are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
After this grant, Porto directly holds several blocks of common stock, including 1,455 newly granted restricted shares and other vested holdings, as well as indirect holdings through a law firm pension plan and a deferred compensation plan. No derivative securities are reported.
Bankwell Financial Group director Lawrence B. Seidman received a new equity grant in the company. On February 9, 2026, he was awarded 1,455 shares of Bankwell common stock as restricted stock at a price of $0 under the 2022 Stock Plan.
The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029, aligning his compensation with longer-term performance. The filing also lists his existing direct holdings and substantial indirect ownership through several investment entities and plans.
Bankwell Financial Group, Inc. reported an equity grant to Chief Innovation Officer Ryan Jason Hildebrand. On February 9, 2026, he was awarded 3,116 shares of common stock at $0 under the 2022 Stock Plan.
Of this grant, 1,558 shares are time-based restricted stock vesting in three equal annual installments starting on February 7, 2027. The remaining 1,558 shares are performance restricted stock that vest on February 7, 2029 if the performance goal is achieved. Following the reported transaction, he directly beneficially owns 3,116 shares from this grant, 3,334 other common shares, and 15,000 performance restricted shares from earlier awards, all under the same 2022 Stock Plan.
Bankwell Financial Group EVP & CFO Courtney E. Sacchetti reported equity compensation and a related share sale in common stock of Bankwell Financial Group, Inc.
On February 9, 2026, Sacchetti received 1,994 common shares at $0 under the 2022 Stock Plan. According to the footnotes, 997 of these are time-based restricted stock vesting in three annual installments starting February 7, 2027, and 997 are performance restricted stock with a three-year cliff vesting on February 7, 2029 if performance goals are achieved.
Also on February 9, 2026, Sacchetti was granted and vested an additional 245 shares tied to 2024 and 2025 performance. To cover tax liabilities for vesting a total of 2,220 shares, 1,062 shares were withheld and sold through a company-sponsored cashless stock exercise program at a reported price of $49.79 per share, within a range of $49.47–$50.21. Following these transactions, Sacchetti reported direct ownership positions across several restricted and performance-based stock grants with varying vesting schedules.
Bankwell Financial Group EVP & Chief Credit Officer Christine Chivily reported multiple stock transactions on February 9, 2026. She received 2,054 shares under the 2022 stock plan, split between time-based restricted stock vesting from February 7, 2027 and performance shares that may cliff vest on February 7, 2029 if goals are met.
She also received and immediately vested 581 performance-related shares tied to 2023–2025 awards. To cover tax liabilities on a total of 4,232 vested shares, 1,985 shares were withheld and sold through a company cashless program at prices ranging from $49.38 to $50.15, leaving her with 16,186 directly held common shares plus previously granted restricted and performance awards.
Bankwell Financial Group, Inc. principal accounting officer Angelo G. Fusaro reported stock compensation and a related tax sale. On February 9, 2026, he received 414 shares of common stock at $0 under the 2022 Stock Plan, vesting in three equal annual installments starting on February 7, 2027.
On the same date, 316 shares were sold at $49.88 through a company cashless program to cover taxes on the vesting of 852 shares. Following these transactions, he directly owned 2,273 common shares, and the filing outlines several prior restricted stock grants under the 2022 plan with staggered vesting through future years.
Bankwell Financial Group Inc. is the issuer for a planned Rule 144 sale of common stock. A holder filed to sell 1,062 shares of common stock with an aggregate market value of $52,874.00 through Citigroup Global Markets on NASDAQ, with an approximate sale date of 02/09/2026.
The 1,062 shares were acquired on 02/09/2026 via restricted stock vesting from Bankwell Financial Group Inc. as compensation. The filing notes that the person signing does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Bankwell Financial Group Inc. has a planned stock sale disclosed under Rule 144. A shareholder filed to sell 3,794 shares of common stock through Citigroup Global Markets on or about 02/09/2026, with an aggregate market value of $189,071.00 on the NASDAQ.
The 3,794 shares were acquired on 02/09/2026 via restricted stock vesting from Bankwell Financial Group Inc. as compensation. The filing notes that 7,877,443 shares of common stock were outstanding, providing context for the size of the proposed sale.
Bankwell Financial Group, Inc. received a notice that a shareholder plans to sell 1,985 shares of its common stock under Rule 144. The shares, valued at an aggregate market price of $98,852.00, are to be sold through Citigroup Global Markets on NASDAQ around February 9, 2026.
The shares come from restricted stock that vested on February 9, 2026, as compensation from Bankwell Financial Group, Inc. The filing also notes that Christine Chivily sold 2,533 common shares on November 12, 2025, generating gross proceeds of $116,164.21.